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Abstract 26 
Vibrio vulnificus is a halophilic estuarine bacterium while it causes fatal septicemia or 27 
necrotizing wound infections in humans. This pathogen secretes the metalloprotease (V. 28 
vulnificus protease: VVP) and cytolysin (V. vulnificus hemolysin: VVH) as protein toxins; 29 
however, their production was coordinated in response to the bacterial cell density. This 30 
regulation is termed quorum sensing (QS) and is mediated by the small diffusible molecule 31 
called autoinducer 2 (AI-2). In the present study, we investigated effects of disruption of luxO 32 
encoding a central response regulator of the QS circuit, as well as effects of temperature and 33 
growth phase, on the toxin production by V. vulnificus. Disruption of luxO was found to 34 
increase VVP production and expression of its gene vvpE. The expression of smcR, crp and 35 
rpoS, of which products positively regulate vvpE expression, and luxS encoding the AI-2 36 
synthetase were also significantly increased. On the other hand, the luxO disruption resulted 37 
in reduction of VVH production and expression of its gene vvhA. Expression of other two 38 
genes affecting the QS circuit, luxT and rpoN, were also significantly decreased. The 39 
regulation systems of VVP production were found to exert their action during the stationary 40 
phase of the bacterial growth and to be operated strongly at 26°C. By contrast, those of VVH 41 
production apparently started at the log phase and were operated more effectively at 37°C. 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
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Introduction 51 
In pathogenic bacteria, coordinated regulation of the virulence gene expression is critical 52 
to successful colonization, invasion, in vivo growth and/or in situ toxin production. The 53 
bacterial virulence is often regulated by temperature, and this regulation occurs at both 54 
transcription and translation level (Hurme and Rhen 1998). Transfer from a natural reservoir 55 
to an infectious host offers a number of cues, which induce the signal transmission to turn on 56 
the virulence potentials (Hurme and Rhen 1998). 57 
Vibrio vulnificus is a gram-negative halophilic estuarine bacterium, while it is an 58 
opportunistic human pathogen causing rapidly progressing fatal septicemia and necrotizing 59 
wound infection (Jones and Oliver 2009). The infectious diseases are preferentially in 60 
susceptible patients with hepatic diseases, hemochromatosis, heavy alcohol drinking habits, 61 
and other immunocompromised conditions (Jones and Oliver 2009). Virulence of V. vulnificus 62 
is multifactorial (Milton 2006), and the bacterium produces various kinds of virulent or toxic 63 
factors including capsular polysaccharides, type IV pilli, hemolytic/cytolytic toxin, and 64 
proteolytic enzymes (Linkous and Oliver 1999; Strom and Paranjpye 2000). However, the 65 
metalloprotease (V. vulnificus protease: VVP/VvpE) and hemolysin (V. vulnificus hemolysin: 66 
VVH/VvhA) are most important toxins (Milton 2006). VVP causes serious hemorrhagic skin 67 
damage through digestion of the vascular basement membrane, especially type IV collagen 68 
forming the framework of the membrane (Miyoshi et al. 2001). It also elicits edema formation 69 
through induction of exocytotic histamine release from mast cells (Miyoshi et al. 2003) and/or 70 
activation of the factor XII-plasma kallikrein-kinin cascade (Miyoshi et al. 2004). On the 71 
other hand, VVH exhibits powerful hemolytic and cytolytic activities (Gray and Kreger 1985), 72 
and it causes vasodilation and may play a significant role in hypotensive septic shock (Kook 73 
et al. 1996). 74 
V. vulnificus coordinates expression of virulence genes in response to the bacterial cell 75 
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density. This regulation is termed quorum sensing (QS), which is mediated by the small 76 
diffusible signal molecule called autoinducer 2 (AI-2) (Federle and Bassler 2003; Henke and 77 
Bassler 2004). Indeed, V. vulnificus possesses LuxS (the AI-2 synthetase), membrane bound 78 
sensor protein LuxPQ, LuxU-LuxO (the response regulators of QS circuit of V. vulnificus), 79 
and SmcR (the master transcriptional regulator for target genes controlled by the QS system) 80 
(McDougald et al. 2000; McDougald et al. 2001; Shao and Hor 2001; Chen et al. 2003; Kim 81 
et al. 2003; Kawase et al. 2004). Moreover, five small RNAs (sRNAs) regulating SmcR were 82 
also predicted, as well as Vibrio cholerae and Vibrio harveyi (Lenz et al. 2004). Besides, Roh 83 
et al. (2006) identified LuxT as the transcriptional regulator of SmcR. At low cell density, 84 
when the signal molecule AI-2 is absent, LuxPQ functions as kinase and it acts on LuxU and 85 
add phosphate group to the protein. The phosphorelay protein LuxU then transfers the 86 
phosphate group to LuxO. Therefore, at low cell density, LuxO remains phosphorylated which 87 
is the active form of the protein. Active LuxO is association with sigma factor 54 RpoN, 88 
activates expression of sRNAs (small regulatory RNAs). The sRNAs along with sRNA 89 
binding protein Hfq represses the transcriptional regulator SmcR (Milton 2006). Also active 90 
LuxO activates the expression of LuxT which is a negative regulator of SmcR (Roh et al. 91 
2006). On the other hand at high cell density, when there is sufficient concentration of the 92 
signal molecule AI-2, it interacts with its specific sensor LuxPQ and converts its function 93 
from kinase to phosphatase. Subsequently the sensor protein dephosphorylates LuxO via 94 
LuxU. The dephosphorylated LuxO is inactive and it cannot activate the expression of sRNAs 95 
or LuxT. As a result SmcR is not inhibited any more. Therefore, at high cell density, SmcR 96 
functions actively and results in change of transcriptional status of the target genes (Milton 97 
2006; Roh et al. 2006). In V. vulnificus, both AI-2 and SmcR positively regulate VVP 98 
production while negatively regulate VVH production (Shao and Hor 2001; Kim et al. 2003; 99 
Kawase et al. 2004). However, the primary target of V. vulnificus QS cascade may be VVP 100 
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because VVP production is regulated more strongly (Milton 2006; Kim and Shin 2010; Kim 101 
and Shin 2011). In addition to QS, two global regulators, namely RpoS (the stationary-phase 102 
sigma factor) and CRP (cAMP-receptor protein) responsible for catabolic repression, are 103 
known to control directly expression of vvpE encoding VVP (Kim and Shin 2011). 104 
In the present study, we outlined effects of disruption of luxO on production of VVP and 105 
VVH, and on expression of their genes (vvpE and vvhA). In addition, we examined expression 106 
of genes consisting of the QS cascade (luxS, luxT and smcR) and those related to the QS 107 
cascade, rpoN that activates expression of sRNAs, hfq that acts together with sRNAs (Milton 108 
2006), rpoS and crp. The expression of rpoD, the house keeping sigma factor during log 109 
phase, was also examined. These experiments were carried out at two different temperatures, 110 
26°C (around estuarine temperature in the summer season) and 37°C (around human intestinal 111 
temperature) and at different phases of the bacterial growth. 112 
 113 
 114 
Materials and Methods 115 
Bacterial strains, plasmids and culture conditions 116 
Bacterial strains and plasmids used in this study are listed in Table 1. Escherichia coli 117 
strains were grown on Luria-Bertani (LB) agar plate or in LB broth containing 0.5% NaCl, 118 
and when required an appropriate antibiotic was added to the media as follows: 119 
chloramphenicol 10 µg/ml, streptomycin 50 µg/ml and kanamycin 50 µg/ml. 120 
For cultivation of V. vulnificus strains, TYE broth (0.5% tryptone, 0.25% yeast extract, 121 
2% NaCl, 25 mM K2HPO4, pH 7.5) was used. Thiosulfate-citrate-bile-salts-sucrose (TCBS) 122 
agar plate containing chloramphenicol 10 µg/ml was used to select luxO mutants. In all 123 
experiments, V. vulnificus was cultivated in TYE broth (5 ml) at 37°C with shaking overnight 124 
(strain YY0507, the luxO mutant, was cultivated in TYE broth containing chloramphenicol 10 125 
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µg/ml), and then, an aliquot of the first culture was taken and re-cultivated in fresh TYE broth 126 
at either 26°C or 37°C till reaching the desired phase of growth. 127 
For the AI-2 assay, autoinducer bioassay (AB) broth (1 mM L-arginine, 2% glycerol, 10 128 
ng/ml riboflavin, 1 µg/ml thiamin, 300 mM NaCl, 10 mM K2HPO4, 50 mM MgSO4, 0.2% 129 
casamino acids; pH 7.5) was used. 130 
 131 
Construction of the luxO mutant and its revertant 132 
The luxO mutant was constructed by the single crossover homologous recombination as 133 
described previously (Nishibuchi et al. 1991; Funahashi et al. 2002). The 781 bp region of 134 
luxO was amplified by PCR using a primer set luxO-1, a forward primer containing the 135 
recognition sequence for XbaI (TCTAGA) and a reverse primer containing the recognition 136 
sequence for EcoRI (GAATTC) (Table 2), and digested with XbaI and EcoRI. The 137 
XbaI-EcoRI digested PCR product was inserted into the suicide vector pKTN701 (Nishibuchi 138 
et al. 1991). The hybrid plasmid obtained was transformed into E. coli SY327λpir, then into E. 139 
coli SM10λpir. Thereafter, it was transferred to V. vulnificus L-180 by conjugation, and the 140 
conjugants were cultivated on TCBS agar plates containing chloramphenicol. One suitable 141 
luxO mutant named strain YY0507 was selected by 48 h cultivation at 37°C, and disruption of 142 
the luxO gene was confirmed by PCR. The revertant named strain AAER12 was obtained by 143 
repeated sub-culturing of strain YY0507 in LB broth at 37°C, and reversion of the gene was 144 
confirmed by PCR. 145 
 146 
Measurement of bacterial growth 147 
V. vulnificus strains were grown at 37°C under aeration in TYE broth (5 ml) overnight 148 
with shaking. Then, an aliquot of the first culture was taken and re-cultivated in fresh TYE 149 
broth at 26°C or 37°C, and the growth monitored by measuring the optical density at 600 nm 150 
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(OD600) of the cultures every 1 h. Then, the growth curves were drawn. Thereafter, early log 151 
phase, late log phase, early stationary phase, and stationary phase were determined. 152 
 153 
RT-PCR  154 
Total RNA was extracted from the bacterial cells cultivated at 26°C or 37°C at early log, 155 
late log or early stationary phase, by using RNeasy Mini Kit (Qiagen GmbH, Hilden, 156 
Germany) according to the manufacturer’s manual. Total RNA thus obtained was added to the 157 
Ready-To-Go RT-PCR kit (GE Healthcare Bio-science, Buckinghamshire, UK) and incubated 158 
at 42°C for 30 min for reverse transcription. Thereafter, the reverse transcriptase was 159 
inactivated by heating at 95°C for 5 min, and PCR amplification with an appropriate primer 160 
set (Table 2) was performed as follows: 30 s denaturation at 95°C, 30 s annealing at an 161 
appropriate temperature, and 60 s extension at 72°C. The PCR products were electrophoresed 162 
on a 1.5% agarose gel and visualized by staining with ethidium bromide and the intensity of 163 
bands were analyzed using imageJ program. The relative amount of each mRNA was 164 
estimated using the amount of mRNA of the house keeping gene 16s rRNA as 1.0. 165 
 166 
Assay of VVP, VVH and AI-2 activity 167 
Quantitative assays of VVP, VVH and AI-2 activity of the culture supernatants were 168 
performed. Cultures of V. vulnificus strains were grown in TYE medium until early log phase, 169 
late log phase, early stationary phase and stationary phase. Cell free culture supernatants were 170 
prepared from these cultures by centrifugation (at 12,000 x g for 5 min at 4°C and filtration 171 
(through 0.2 µm Millipore filter). Sterile TYE medium was used as negative control in the 172 
assays. 173 
The proteolytic activity of VVP was assayed with azocasein (Sigma-Aldrich, St. Louis, 174 
MO, USA) as described by Miyoshi et al. (1987). Briefly, the sample was allowed to act at 175 
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30°C for an appropriate time on 1.0 mg of azocasein in 0.6 ml of 50 mM Tris-HCl buffer (pH 176 
8.0). The reaction was stopped by the addition of 1.4 ml of 5% trichloroacetic acid. After 177 
centrifugation at 5000 g for 5 min, an aliquot of the supernatant was withdrawn and mixed 178 
with the same volume of 0.5 M NaOH. Thereafter, the absorbance at 440 nm was measured. 179 
One protease unit (PU) was defined as the amount of VVP hydrolyzing 1 µg of the substrate 180 
in 1 min. 181 
The hemolytic activity of VVH was assayed with 1% sheep erythrocytes as described by 182 
Shinoda et al. (1985). Briefly, the sample (0.6 ml) was allowed to act on the erythrocytes (0.6 183 
ml) at 37°C for 2 h in 20 mM Tris-HCl buffer containing 0.9% NaCl (pH 7.5). Thereafter, the 184 
reaction mixtures were centrifuged at 1000 g for 5 min, and the amount of hemoglobin 185 
released from the disrupted erythrocytes was determined by measuring the absorbance of the 186 
supernatant at 540 nm. One hemolysin unit (HU) was defined as the amount of VVH eliciting 187 
50% hemoglobin release. 188 
The AI-2 activity was measured using the reporter strain V. harveyi BB170 as described 189 
by Bassler et al. (1993). Briefly, the reporter strain was cultured overnight in LB broth 190 
containing 3.0% NaCl at 30°C. The bacterial culture was diluted 1:5000 with AB broth. An 191 
aliquot of the diluted culture (540 µl) was mixed with 60 µl of the sample, and the mixture 192 
was cultivated at 30°C for 4 h with shaking. Thereafter, the intensity of bioluminescence 193 
(relative light unit: RLU) was measured with a luminometer K-210 (Kikkoman, Tokyo, 194 
Japan). In these experiments, the supernatant from V. harveyi BB152, a mutant producing only 195 
AI-2, was used as the 100% control. 196 
 197 
Western blot analysis 198 
For Western blot analysis, proteins in the sample were precipitated by mixing with the 199 
same volume of 25% tricloroacetic acid, and collected by centrifugation for 5 min at 15000 g 200 
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at 4°C. Thereafter, the protein collected were washed by 100% ethanol, treated with 2% 201 
sodium dodecyl sulfate (SDS) at 100°C for 5 min and subjected to SDS-PAGE on the 202 
PhastSystemTM using a PhastGelTM Gradient 10-15 (GE Health Bio-Sciences). After 203 
SDS-PAGE, the proteins separated were transferred to a polyvinylidene difluoride (PVDF) 204 
membrane (GE Health Bio-Sciences). The membrane with the bound proteins was then 205 
incubated with rabbit IgG antibody against VVP or VVH, and the antigen-antibody complex 206 
was visualized using the antibody against rabbit IgG conjugated with horseradish peroxidase 207 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and a chromogenic substrate 208 
4-methoxy-1-naphthol and hydrogen peroxide. 209 
 210 
Statistical analysis 211 
To evaluate the significance of difference in the results, all experiments were repeated at 212 
least three times, the data were compared by Student t-test, and the P values less than 0.05 213 
were considered significantly different. 214 
 215 
 216 
Results 217 
Construction of the luxO mutant and its revertant 218 
To clarify inactivation of the luxO gene, the RNA preparations from the luxO mutant 219 
(strain YY0507, luxO::Cmr), the revertant (strain AAER12), as well as the wild type strain 220 
(strain L-180), were analyzed by RT-PCR. As shown in Fig. 1A, in the case of strain L-180 221 
and AAER12, the significant transcription of luxO was observed; however, the luxO mRNA 222 
could not be detected in strain YY0507. 223 
The luxO gene makes an operon with a downstream gene luxU. Therefore, the RT-PCR 224 
experiments targeting the luxOU mRNA also showed that null expression of the operon in the 225 
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luxO mutant (Fig. 1B). However, the comparative amount of luxU mRNA was detected in all 226 
strains (Fig. 1B), indicating the luxU gene has own promoter and it functions normally in the 227 
luxO mutant. 228 
 229 
Growth of the luxO mutant and its revertant 230 
Strain YY0507 was found to grow slightly faster than the wild type strain at both 26°C 231 
and 37°C; however, the growth speed of strain AAER12, the revertant from strain YY0507, 232 
was the same as that of the wild type strain (Fig. 2). 233 
 234 
Expression of sigma factor genes (rpoD, rpoS and rpoN) 235 
By disruption of luxO gene, the rpoD expression was significantly increased at log and 236 
early stationary phase, and the expression of rpoS was also increased at late log and early 237 
stationary phase (Fig. 3). On the other hand, disruption of luxO resulted in decrease in the 238 
expression of rpoN at late log and early stationary phase (Fig. 3). It should be noted that 239 
expression of rpoD and rpoS gene at 26°C was higher than at 37°C, but rpoN was more 240 
expressed at 37°C (Fig. 3). 241 
 242 
Expression of the QS cascade genes (luxS, luxT and smcR), crp and hfq 243 
As shown in Fig. 4, disruption of luxO resulted in significant increase in the expression of 244 
luxS, smcR and crp genes at late log and early stationary phase, and these genes were 245 
expressed more at 26°C. By contrast, expression of luxT was decreased by disruption of luxO, 246 
and the transcription level of luxT was higher at 37°C. On the other hand, no significant 247 
difference of hfq expression was observed by disruption of luxO gene (data not shown). 248 
 249 
 250 
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Expression of vvpE and vvhA gene 251 
Expression of vvpE and vvhA was highly dependent on the bacterial growth and 252 
cultivation temperature (Fig. 5). Namely, vvpE expression was maximum at early stationary 253 
phase and was distinctly higher at 26°C. Although transcription of vvpE gene was started at 254 
log phase, upon the entry in the stationary phase, its level was increased about 10 times. On 255 
the other hand, vvhA was most expressed at log phase at 37°C. 256 
The disruption of luxO gene showed apparent increase in the vvpE expression. As shown 257 
in Fig. 5A, the transcription level of vvpE gene in the luxO-disrupted strain YY0507 was 258 
markedly higher than that of strain L-180 and AAER12. By contrast, the luxO disruption 259 
resulted in significant decrease in the expression of vvhA (Fig. 5B). 260 
 261 
Production of VVP, VVH and AI-2 262 
The VVP activity in the culture supernatant was highly dependent on the bacterial growth 263 
and cultivation temperature. Upon the entry in the stationary phase, the activity was increased 264 
about 10 times of that at log phase, and the activity was distinctly higher at 26°C (Fig. 6A). 265 
By Western blot analysis, the VVP antigen could not be detected at early log phase; however, 266 
the antigen was steadily detected at late log and stationary phase (Fig. 6B). The disruption of 267 
luxO caused increase in production of VVP. The activities of VVP in the culture supernatants 268 
from strain YY0507 were significantly higher than those of strain L-180 and AAER12, and 269 
more steadily bands of the VVP antigen were detected when the culture supernatants of strain 270 
YY0507 were analyzed by Western blotting (Fig. 6). 271 
The VVH activity in the culture supernatant was also dependent on the bacterial growth 272 
and cultivation temperature. However, in contrast to the VVP activity, the VVH activity was 273 
apparently higher when cultivated at 37°C, and the highest activity was detected in the culture 274 
supernatant at late log phase (Fig. 7). Additionally, disruption of luxO gene resulted in 275 
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significant decrease in the activity caused by VVH at both cultivation temperatures (Fig. 7). 276 
As well as VVP and VVH, the activity of AI-2 was highly dependent on the bacterial 277 
growth and cultivation temperature. The activity reached a maximum level at early stationary 278 
phase of cultivation at 26°C (Fig. 8). The luxO-disrupted mutant YY0507 showed the higher 279 
activity than the wild type strain and the revertant strain, indicating negative regulation of 280 
luxS by LuxO. 281 
 282 
 283 
Discussion 284 
V. vulnificus inhabits sea water or brackish water, but it can cause infection in human. 285 
During the infection process, V. vulnificus must sense and sustain changes in environmental 286 
factors. The most important environmental difference in many respects is temperature (Lee et 287 
al. 2007). Signals from the changing environmental factors are relayed to specific genes by 288 
cognate signal transduction systems, resulting in the expression of genes including specific 289 
virulence factor genes. Virulence factors required for in vivo survival and growth are 290 
produced at an appropriate place and time in a tightly regulated fashion (Heithoff et al. 1997; 291 
Lee et al. 1999; Kim et al; 2007). In V. vulnificus, VVP is the best-known virulence factor 292 
regulated by various environmental signals (Jeong et al. 2003; Kim et al. 2003; Roh et al. 293 
2006; Kim and Shin 2011), and three global regulators, RpoS, SmcR, and CRP, have been 294 
reported to control directly production of VVP (Chiang and Chuang 2003; Kim and Shin 295 
2010; Kim and Shin 2011). Here we studied the effects of disruption of luxO, which encodes 296 
the master regulator on QS cascade, on the expression of the genes of three global regulators 297 
at different temperatures, 26°C and 37°C at different phases of the bacterial growth. Also, the 298 
effects of luxO disruption on the expression of sigma factor genes, the QS cascade genes, 299 
vvpE and vvhA genes, and production of VVP, VVH and AI-2 were examined. 300 
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Our results demonstrated that V. vulnificus produced two protein toxins, VVP and VVH, 301 
at specific times of the bacterial growth in a tightly regulated fashion. As summarized in Table 302 
3, disruption of luxO showed increased expression of rpoS, luxS, smcR, crp and vvpE at 303 
stationary phase. Production of AI-2 and VVP was also distinctly higher in the luxO mutant. 304 
However, at log phase, the vvpE expression and VVP production was not increased. Two 305 
promoters, promoter L (PL) and promoter S (PS), are known to direct differentially 306 
transcription of the vvpE gene in a growth phase-dependent manner (Jeong et al. 2001, Jeong 307 
et al. 2003, Jeong et al. 2010). The PL activity is constitutive through the log and stationary 308 
phases, but is lower than the PS activity. The transcription from PS is induced only in the 309 
stationary phase and is dependent on RpoS, CRP and SmcR. These findings put the light on 310 
the exact time of SmcR, CRP and RpoS regulation of vvpE expression, namely, the regulation 311 
occurs only upon the entry to the stationary phase. Because transcription of vvpE from PL is 312 
starting from the log phase, RNA polymerase with RpoD, the log phase housekeeping sigma 313 
factor, would recognize the PL. However, in the present study, it was not confirmed that 314 
RpoD has significant role in VVP production during log phase. Although rpoD expression 315 
was significantly increased in the luxO mutant, vvpE transcription and VVP production were 316 
no significant difference from both the wild type strain and the revertant strain. 317 
As summarized in Table 4, it is clear that both the cultivation temperature and growth 318 
phase are very critical determinants for regulation of expression vvpE and vvhA gene. The 319 
transcription level of vvpE and production of VVP were distinctly higher at 26°C. It is also 320 
noteworthy that the expression of genes encoding positive regulators of vvpE (smcR, rpoS and 321 
crp) and AI-2 synthetase (luxS), and the AI-2 production were also higher at 26°C. Taken 322 
together, it is concluded that the regulation systems for VVP production are operated strongly 323 
at 26°C, but not at 37°C. Therefore, as documented previously by Kawase et al. (2004), V. 324 
vulnificus produces a significant amount of VVP only in the interstitial tissue of limbs, in 325 
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which temperature is lower than that in the small intestine and the blood-stream, and VVP 326 
produced causes serious hemorrhagic and edematous skin damage (Miyoshi et al. 2001; 327 
Miyoshi et al. 2003; Miyoshi et al. 2004). 328 
In contrast to VVP, the production of VVH started during log phase and reached a 329 
maximum level at late log phase. Disruption of luxO resulted in decreased expression of vvhA 330 
and less production of VVH. It is also noteworthy that, at 37°C, the expression of rpoN was 331 
higher at log phase. This may indicate that RNA polymerase with RpoN recognizes the 332 
promoter of vvhA gene. Taken together, it is concluded that the regulation systems for VVH 333 
production are operated effectively at 37°C. Therefore, V. vulnificus produces an enough 334 
amount of VVH in the small intestine, which results in acceleration of the bacterial invasion 335 
to the blood-stream. 336 
 337 
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Figure legends 451 
Fig. 1. Expression of luxO, luxOU and luxU. In order to confirm inactivation of luxO in the 452 
luxO mutant strain YY0507 and its reversion in strain AAER12, total RNA was prepared from 453 
each strain, and RT-PCR to detect luxO (A), luxOU (B), or luxU mRNA (B) was carried out. 454 
The 16S rRNA was used as the positive control. Lane M; 1-kb DNA ladder, lane 1; strain 455 
L-180, lane 2; strain YY0507 and lane 3; strain AAER12. 456 
 457 
Fig. 2. Growth of the bacterial strains at 26°C (A) and 37°C (B). Strain L-180 (grey diamond), 458 
YY0507 (black square) and AAER12 (white triangle) were cultivated in TYE broth at 26°C or 459 
37°C, and the optical density at 600 nm (OD600) was measured every 1 h. Thereafter, early log 460 
phase (a), late log phase (b), early stationary phase (c), and stationary phase (d) were 461 
determined. Data represent the mean of three experiments. 462 
 463 
Fig. 3. Effect of luxO disruption on expression of rpoD (A), rpoS (B) and rpoN (C). Strain 464 
L-180 (grey bar), YY0507 (black bar) and AAER12 (white bar) were cultivated in TYE broth 465 
at 26°C or 37°C, total RNA was extracted at early log phase (a), late log phase (b) and early 466 
stationary phase (c), and the level of mRNA was measured by RT-PCR. Thereafter, PCR 467 
products were electrophresed on 1.5% agarose gel, visualized by staining with ethidium 468 
bromide and analyzed by imageJ program. The amount of mRNA was represented using the 469 
amount of 16s rRNA as 1.00. The data is the mean + S.D. of three experiments. The asterisk 470 
(*) indicates the significant difference (P < 0.05) between strain YY0507 and both strain 471 
L-180 and AAER12. 472 
 473 
Fig. 4. Effect of luxO disruption on expression of luxS (A), luxT (B) and smcR (C) and crp 474 
(D). Strain L-180 (grey bar), YY0507 (black bar) and AAER12 (white bar) were cultivated in 475 
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TYE broth at 26°C or 37°C, total RNA was extracted at early log phase (a), late log phase (b) 476 
and early stationary phase (c), and the level of mRNA was measured by RT-PCR. Thereafter, 477 
PCR products were electrophresed on 1.5% agarose gel, visualized by staining with ethidium 478 
bromide and analyzed by imageJ program. The amount of mRNA was represented using the 479 
amount of 16s rRNA as 1.00. The data is the mean + S.D. of three experiments. The asterisk 480 
(*) indicates the significant difference (P < 0.05) between strain YY0507 and both strain 481 
L-180 and AAER12. 482 
 483 
Fig. 5. Effect of luxO disruption on expression of vvpE (A) and vvhA (B). Strain L-180 (grey 484 
bar), YY0507 (black bar) and AAER12 (white bar) were cultivated in TYE broth at 26°C or 485 
37°C, total RNA was extracted at early log phase (a), late log phase (b) and early stationary 486 
phase (c), and the level of mRNA was measured by RT-PCR. Thereafter, PCR products were 487 
electrophresed on 1.5% agarose gel, visualized by staining with ethidium bromide and 488 
analyzed by imageJ program. The amount of mRNA was represented using the amount of 16s 489 
rRNA as 1.00. The data is the mean S.D. of three experiments. The asterisk (*) indicates the 490 
significant difference (P < 0.05) between strain YY0507 and both strain L-180 and AAER12. 491 
 492 
Fig. 6. The activity of VVP in the culture supernatants (A) and Western blot analysis of the 493 
VVP antigen (B). (A) Culture supernatants were prepared from early log phase (a), late log 494 
phase (b), early stationary phase (c) and stationary phase (d) of growth of L-180 (grey bar), 495 
YY0507 (black bar) and AAER12 (white bar). The activities of VVP (PU/ml) in the culture 496 
supernatants were determined using azocasein as substrate, and the specific protease activity 497 
(PU/OD600) was calculated. The data is the mean + S.D. of three experiments. The asterisk (*) 498 
indicates the significant difference (P < 0.05) between YY0507 and both strain L-180 and 499 
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AAER12. (B) Western blot analysis of the VVP antigen was performed by precipitating the 500 
proteins in the collected culture supernatants by adding the same volume of 25% 501 
tricloroacetic acid, the protein pellets was washed by 100% ethanol, dissolved by suspending 502 
in SDS sample buffer and boiled for 5 min, and an aliquot of each preparation was subjected 503 
to SDS-PAGE. Thereafter, the proteins were transferred to a PVDF membrane, and VVP 504 
antigens were detected with the antibody against purified VVP. Lane 1; strain L-180, lane 2; 505 
strain YY0507 and lane 3; strain AAER12. 506 
 507 
Fig. 7. The activity of VVH in the culture supernatants (A) and Western blot analysis of the 508 
VVH antigen (B). (A) Culture supernatants were prepared from early log phase (a), late log 509 
phase (b), early stationary phase (c) and stationary phase (d) of growth of L-180 (grey bar), 510 
YY0507 (black bar) and AAER12 (white bar). The activities of VVH (HU/ml) in the culture 511 
supernatants were determined using 1% sheep erythrocytes, and the specific hemolysin 512 
activity (HU/OD600) was calculated. The data is the mean + S.D. of three experiments. The 513 
asterisk (*) indicates the significant difference (P < 0.05) between YY0507 and both L-180 514 
and AAER12. (B) Western blot analysis of the VVH antigen was performed by precipitating 515 
the proteins in the collected culture supernatants by adding the same volume of 25% 516 
tricloroacetic acid, the protein pellets was washed by 100% ethanol, dissolved by suspending 517 
in SDS sample buffer and boiled for 5 min, and an aliquot of each preparation was subjected 518 
to SDS-PAGE. Thereafter, the proteins were transferred to a PVDF membrane, and VVH 519 
antigens were detected with the antibody against purified VVH. Lane 1; strain L-180, lane 2; 520 
strain YY0507 and lane 3; strain AAER12. 521 
 522 
Fig. 8. AI-2 activity in the culture supernatants. Culture supernatants were prepared from 523 
early log phase (a), late log phase (b), early stationary phase (c) and stationary (d) of growth 524 
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of L-180 (grey bar), YY0507 (black bar) and AAER12 (white bar). Culture supernatants of 525 
test bacteria (60 µl) were added to the diluted reporter strain V. harveyi BB170 (540 µl) and 526 
incubated at 30°C with shaking for 4 h. Bioluminescences of 600 µl aliqoutes of samples 527 
were measured with a luminometer, Lumitester K-210 (Kikkoman, Tokyo, Japan) that 528 
measured the amount of bioluminescence in Relative Luminescence Unit (RLU). In these 529 
experiments, the supernatant from V. harveyi BB152 was used as one. The data is the mean + 530 
S.D. of three experiments. The asterisk (*) indicates the significant difference (P < 0.05) 531 
between YY0507 and both L-180 and AAER12. 532 
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Fig. 1. Construction of the luxO-knock out mutant and revertant strains 563 
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Fig. 2. Growth of the luxO-disrupted mutant and revertant strains 578 
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Fig. 3. Expression of rpoD, rpoS and rpoN 596 
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Fig. 4. Expression of luxS, luxT, smcR and crp 604 
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Fig. 5. Expression of vvpE and vvhA 647 
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Fig. 6. Production of VVP 665 
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Fig. 7. Production of VVH 671 
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Fig. 8. Production of AI-2 677 
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Table 1 Bacterial strains and plasmids used 713 
 714 
Strain or plasmid Relevant features a Reference 
Vibrio vulnificus 
L-180 
 
Clinical isolate; virulent  
 
(Miyoshi et al. 1987) 
YY0507 L-180 strain, luxO::Cmr This study 
AAER12 Revertant strain of YY0507.  This study 
Escherichia coli 
SY327λpir 
 
△(lac pro), argE(Am), rif, nalA, recA56, 
rpoB, λpir, Smr, host for π-requiring 
plasmids. 
(Miller and Mekalanos 1988) 
SM10λpir 
thi-1, thr, leu, tonA, lacY, supE, 
recA::RP4-2-Tc::Mu, λpir, oriT of RP4, 
Kmr; conjugational donor. 
(Simon et al. 1983) 
Vibrio harveyi  
BB170 
 
Reporter strain used in auto-inducer 2 
assay.  
 
(Bassler et al. 1993) 
BB152  
Positive control strain used in 
auto-inducer 2 assay. 
(Bassler et al. 1993) 
Plasmids 
pKTN701 
 
R6K-ori suicide vector for gene 
replacement; Cmr. 
 
(Nishibuchi et al. 1991) 
pKTY0506 pKTN701 with luxO; Cmr.  This study 
a Cmr, chloramphenicol-resistant; Smr, streptomycin-resistant; Kmr, kanamycin-resistant. 715 
 716 
 717 
 718 
 719 
 720 
 721 
 722 
 723 
 724 
 725 
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Table 2 Oligonucleotide primers used 726 
 727 
Gene 
Accession 
number 
Nucleotide sequence 5’~ 3’ Position 
16s rRNA  X76334 Forward CATGATGCCTACGGGCCAAA 171--190 
  Reverse TGCCGCTATTAACGACACCAC 447--467 
luxO-1 
a
 BA000037 Forward GCTCTAGAGGTCACGGTAAACAACGCTATC 354--375 
  Reverse GCGAATTCGTTGTTAAGCACCACCACATTAC 1112--1134 
luxO-2 BA000037 Forward CCCTCTATCGCTCCTATCTCATGC 68--91 
  Reverse GTTCAAAGGGCTGGTTCAAAGGAG 1166--1189 
luxU BA000037 Forward CAGAAGAAAATTGCCTCGTTGACAG 49--73 
  Reverse TGCTACCACATCTTGCGTTTCATC 295--318 
luxT AE016796 Forward GCCAAAGCGTAGTAAAGAAG 3--22 
  Reverse GAGACTTACCAAACAGCCAC 423--442 
smcR AF204737 Forward GTTTCTGTGGCGACCGTCTTCAA 389--411 
  Reverse AGCGAGTAACAAATGCCGTGGAA 743--765 
luxS AF401230 Forward CCAAAAGGCGACACCATTAC 82--101 
  Reverse CAACATCGCTTCTGGCAATG 479--498 
rpoD EF642870 Forward ACTCAGCTTCGTAACAGCTACC 1--22 
  Reverse ATCAACCGCTTTCATCAGACCG 567--588 
rpoS AY163815 Forward TATGCTCGACGTGCATTACG 4--23 
  Reverse TAACGCCTTCTCTCCATCTC 452--471 
rpoN CP002469 Forward CAAGCTAGGTCAACAGTTAGCC 21--42 
  Reverse ACTGTTGGATGCGTTTGCGTAC 568--589 
hfq CP002469 Forward ATGGCTAAGGGGCAATCTCTAC 1--22 
  Reverse TCTTCCGATTTCTCGCTTGGAC 236--257 
crp CP002469 Forward TCAAACCGATCCAACACTAGA 18--38 
  Reverse ACCAGTTACGTCTAGGAATGC 406--426 
vvpE  AB084580 Forward CAACAGTAAAACGGGCCGTTATGAG 618--642 
  Reverse TTGAGCCGCTTTGACCACGCCGC 1418--1440 
vvhA  M34670 Forward AGATTAAGTGTGTGTTGCACACAAGCGGTG 110--139 
  Reverse ACCGAAAACAGCGCTGAAGGAAGAACGGTA 894--923 
a The artificial restriction enzyme site is indicated by the underline. 728 
 729 
 730 
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Table 3 Effects of luxO disruption on the gene expression 731 
 732 
Growth phase Increase  Decrease 
26°C 
Log phase 
 
rpoD 
 
 
Stationary phase rpoS, luxS, smcR, crp, vvpE  
37°C 
Log phase 
 
 
 
rpoN, vvhA 
Stationary phase  luxT 
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 757 
Table 4 Growth phase and temperature dependent gene expression 758 
Growth phase 
Cultivation temperature 
26°C 37°C 
Log phase rpoD rpoN, vvhA 
Stationary phase rpoS, luxS, smcR, crp, vvpE luxT 
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